BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  COVID-19 Vaccine: Behind the Scenes of Moderna, the Company Leading the Way

  Moderna has always been an odd and secretive company. Currently all eyes are on the company because it is the furthest along in developing a vaccine against COVID-19.

  July 2, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Genetown

  Amylyx to Continue Pioneering New Treatments for Neurodegenerative Diseases with $30M in Funding

  Massachusetts-based Amylyx Pharmaceuticals, a company focused on developing new treatments for neurodegenerative diseases, announced today that it had concluded a $30 million Series B round of financing.

  July 2, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Drug Development

  Helsinn and MEI Discontinue Phase III Trial of Pracinostat in AML

  The decision was made after an interim futility analysis by an Independent Data Monitoring Committee determined the trial was unlikely to meet the primary endpoint of overall survival (OS) compared to the control group.

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Biopharma Update on the Novel Coronavirus: July 3

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 3, 2020.

  July 2, 2020

   · 

  1 min read

   · 

  BioSpace Editorial Staff
• 

  Drug Development

  Report: Moderna’s Phase III COVID-19 Vaccine Trial Delayed

  It’s not clear how long the trial will be delayed, but according to a report by STAT, it may still begin in July.

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers, July 3

  Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.

  July 2, 2020

   · 

  4 min read

   · 

  Ellen Bombela
• 

  Biotech Bay

  Annexon Raises $100 Million to Advance Therapies for Neurodegenerative, Autoimmune Disorders

  Annexon, based in South San Francisco, closed on a $100 million Series C financing led by Redmile Group.

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Tesla to Build Mobile RNA Microfactories for CureVac’s COVID-19 Vaccine

  The “printers” are portable, automated messenger RNA (mRNA) production units, which Elon Musk referred to as “RNA microfactories.”

  July 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  How to Make a Career Change Later in Life

  Many people stepping into middle age feel that they’re too old to make a career change, but we live in times when an average person changes up to 12 jobs in a lifetime.

  July 2, 2020

   · 

  3 min read

   · 

  Jim Raychrudhury
• 

  BioSpace Global Roundup, July 2

  Biopharma and life sciences companies provide updates on their pipelines and business plans.

  July 2, 2020

   · 

  4 min read

   · 

  Ellen Bombela